GILEAD SCIENCES INC (1GILD.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1GILD - US3755581036 - Common Stock
105.88 EUR
+7.72 (+7.86%)
We assign a fundamental rating of 6 out of 10 to 1GILD. 1GILD was compared to 78 industry peers in the Biotechnology industry. While 1GILD has a great profitability rating, there are some minor concerns on its financial health. 1GILD scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make 1GILD a good candidate for value investing.
1. Profitability
1.1 Basic Checks
1GILD had positive earnings in the past year.
1GILD had a positive operating cash flow in the past year.
Each year in the past 5 years 1GILD has been profitable.
Each year in the past 5 years 1GILD had a positive operating cash flow.
1.2 Ratios
1GILD's Return On Assets of 13.86% is amongst the best of the industry. 1GILD outperforms 85.14% of its industry peers.
Looking at the Return On Equity, with a value of 37.80%, 1GILD belongs to the top of the industry, outperforming 95.95% of the companies in the same industry.
1GILD has a Return On Invested Capital of 18.54%. This is amongst the best in the industry. 1GILD outperforms 91.89% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1GILD is above the industry average of 12.34%.
The 3 year average ROIC (16.22%) for 1GILD is below the current ROIC(18.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.86% | ||
| ROE | 37.8% | ||
| ROIC | 18.54% |
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
1.3 Margins
1GILD has a Profit Margin of 27.88%. This is amongst the best in the industry. 1GILD outperforms 87.84% of its industry peers.
1GILD's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 38.96%, 1GILD belongs to the top of the industry, outperforming 93.24% of the companies in the same industry.
1GILD's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 78.72%, 1GILD is in the better half of the industry, outperforming 68.92% of the companies in the same industry.
In the last couple of years the Gross Margin of 1GILD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.96% | ||
| PM (TTM) | 27.88% | ||
| GM | 78.72% |
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1GILD is creating value.
The number of shares outstanding for 1GILD remains at a similar level compared to 1 year ago.
Compared to 5 years ago, 1GILD has less shares outstanding
Compared to 1 year ago, 1GILD has a worse debt to assets ratio.
2.2 Solvency
There is no outstanding debt for 1GILD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC2.31
WACC8.01%
2.3 Liquidity
1GILD has a Current Ratio of 1.53. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
1GILD has a Current ratio of 1.53. This is comparable to the rest of the industry: 1GILD outperforms 40.54% of its industry peers.
1GILD has a Quick Ratio of 1.17. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
1GILD's Quick ratio of 1.17 is on the low side compared to the rest of the industry. 1GILD is outperformed by 66.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 84.88% over the past year.
1GILD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.01% yearly.
The Revenue has been growing slightly by 2.78% in the past year.
The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
3.2 Future
The Earnings Per Share is expected to grow by 19.75% on average over the next years. This is quite good.
Based on estimates for the next years, 1GILD will show a small growth in Revenue. The Revenue will grow by 4.34% on average per year.
EPS Next Y77.74%
EPS Next 2Y37.95%
EPS Next 3Y27.38%
EPS Next 5Y19.75%
Revenue Next Year1.79%
Revenue Next 2Y2.77%
Revenue Next 3Y3.74%
Revenue Next 5Y4.34%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.93, the valuation of 1GILD can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of 1GILD indicates a rather cheap valuation: 1GILD is cheaper than 86.49% of the companies listed in the same industry.
1GILD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.31.
The Price/Forward Earnings ratio is 13.95, which indicates a correct valuation of 1GILD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1GILD indicates a rather cheap valuation: 1GILD is cheaper than 89.19% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of 1GILD to the average of the S&P500 Index (36.59), we can say 1GILD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.93 | ||
| Fwd PE | 13.95 |
4.2 Price Multiples
1GILD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1GILD is cheaper than 86.49% of the companies in the same industry.
1GILD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1GILD is cheaper than 87.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.94 | ||
| EV/EBITDA | 10.1 |
4.3 Compensation for Growth
1GILD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1GILD has an outstanding profitability rating, which may justify a higher PE ratio.
1GILD's earnings are expected to grow with 27.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y37.95%
EPS Next 3Y27.38%
5. Dividend
5.1 Amount
1GILD has a Yearly Dividend Yield of 2.67%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 12.49, 1GILD pays a better dividend. On top of this 1GILD pays more dividend than 93.24% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, 1GILD has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.67% |
5.2 History
The dividend of 1GILD has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
12.00% of the earnings are spent on dividend by 1GILD. This is a low number and sustainable payout ratio.
1GILD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP12%
EPS Next 2Y37.95%
EPS Next 3Y27.38%
BIT:1GILD (10/20/2025, 7:00:00 PM)
105.88
+7.72 (+7.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners90.76%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap131.38B
Revenue(TTM)29.09B
Net Income(TTM)8.11B
Analysts81.11
Price Target112.24 (6.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.67% |
Yearly Dividend2.72
Dividend Growth(5Y)4.45%
DP12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)2.79%
PT rev (3m)7.28%
EPS NQ rev (1m)-2.63%
EPS NQ rev (3m)2.11%
EPS NY rev (1m)-0.8%
EPS NY rev (3m)0.9%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.93 | ||
| Fwd PE | 13.95 | ||
| P/S | 5.22 | ||
| P/FCF | 15.94 | ||
| P/OCF | 15.7 | ||
| P/B | 7.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.1 |
EPS(TTM)7.09
EY6.7%
EPS(NY)7.59
Fwd EY7.17%
FCF(TTM)6.64
FCFY6.27%
OCF(TTM)6.74
OCFY6.37%
SpS20.29
BVpS14.97
TBVpS-3.37
PEG (NY)0.19
PEG (5Y)N/A
Graham Number48.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.86% | ||
| ROE | 37.8% | ||
| ROCE | 24.51% | ||
| ROIC | 18.54% | ||
| ROICexc | 23.24% | ||
| ROICexgc | 80.87% | ||
| OM | 38.96% | ||
| PM (TTM) | 27.88% | ||
| GM | 78.72% | ||
| FCFM | 32.73% |
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 68.56% | ||
| Profit Quality | 117.39% | ||
| Current Ratio | 1.53 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | N/A |
F-Score7
WACC8.01%
ROIC/WACC2.31
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
EPS Next Y77.74%
EPS Next 2Y37.95%
EPS Next 3Y27.38%
EPS Next 5Y19.75%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
Revenue Next Year1.79%
Revenue Next 2Y2.77%
Revenue Next 3Y3.74%
Revenue Next 5Y4.34%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year75.69%
EBIT Next 3Y25.29%
EBIT Next 5Y19.07%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%
GILEAD SCIENCES INC / 1GILD.MI FAQ
What is the ChartMill fundamental rating of GILEAD SCIENCES INC (1GILD.MI) stock?
ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI.
What is the valuation status of GILEAD SCIENCES INC (1GILD.MI) stock?
ChartMill assigns a valuation rating of 8 / 10 to GILEAD SCIENCES INC (1GILD.MI). This can be considered as Undervalued.
What is the profitability of 1GILD stock?
GILEAD SCIENCES INC (1GILD.MI) has a profitability rating of 8 / 10.
Can you provide the financial health for 1GILD stock?
The financial health rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10.
How sustainable is the dividend of GILEAD SCIENCES INC (1GILD.MI) stock?
The dividend rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10 and the dividend payout ratio is 12%.